Wellpath Partners with Awell to Improve Quality of Care through Data-Driven Improvements
By implementing Awell’s CareOps platform, Wellpath can efficiently implement and optimize its care flows and protocols across its network. This ensures care pathways stay flexible, up to date and ...
Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
The Phase 1/2 trial will assess the safety and clinical activity of IMC-R117C, as a monotherapy and in combination with standards of care, in ...